2025
Genomic data sharing in research across Europe: legal challenges and upcoming opportunities within the European Health Data Space
ROYO, Romina; Eva GARCIA; Irene SCHLÜNDER; Christina HILMARSEN; Mette KIELSHOLM THOMSEN et al.Základní údaje
Originální název
Genomic data sharing in research across Europe: legal challenges and upcoming opportunities within the European Health Data Space
Autoři
ROYO, Romina; Eva GARCIA; Irene SCHLÜNDER; Christina HILMARSEN; Mette KIELSHOLM THOMSEN; Emilie CAUËT; Simon KOK JENSEN; Simona GIARDINA; Aline HEBRANT; Gordana RAICEVIC TOUNGOUZ; Marc VAN DEN BULCKE; Juan ARENAS; Christian FYNBO CHRISTIANSEN; Eivind HOVIG; Petr HOLUB; Alfonso VALENCIA a Salvador CAPELLA-GUTIERREZ
Vydání
EUROPEAN JOURNAL OF PUBLIC HEALTH, OXFORD UNIV PRESS, 2025, 1101-1262
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30304 Public and environmental health
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.900 v roce 2024
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14610/25:00142009
Organizační jednotka
Ústav výpočetní techniky
UT WoS
Klíčová slova anglicky
informed consent heterogeneity ethics committees genome european continental ancestry group principles of law and justice data sharing
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 25. 3. 2026 15:08, Mgr. Eva Špillingová
Anotace
V originále
The European Health Data Space (EHDS) will help researchers use health data across EU Member States (MS). Currently, cross-border research faces heterogeneous data access processes. Using a real-world use case, this paper analyses challenges and opportunities brought by the upcoming implementation of the EHDS, assessing the situation before and after the regulation comes into force. The use case focused on metastatic colorectal cancer, analysing the relations between mutational signatures and clinical trajectories while addressing data access procedures across MS. The regulatory landscape and the challenges that need to be addressed for the EHDS to enable the secondary use of health data, particularly genomic data, are complex and heterogeneous across MS. We describe the pathway from data application to access to pseudonymized data in secure processing environments, emphasizing the legal requirements, including the role of ethics committees. Finally, we analyse the success factors for achieving access to the data and the reasons for access denial to support shaping the upcoming EHDS implementation. Several challenges remain unaddressed for cross-border data use, especially in the context of genomic data, where the complexity and heterogeneity of informed consent can impact or even impede data-sharing efforts. While EHDS can simplify processes across MS, it is crucial to ensure that additional safeguards do not negatively impact or block access to health data and that EHDS infrastructure is ready for effective and affordable processing of large volumes of genomic and other data.
Návaznosti
| 101079839, interní kód MU |
|